ApprovalTrail

Approval · Notice of Compliance 5180 · 1995

NITROGLYCERIN: Notice of Compliance 5180

Issued September 18, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5180
Date
September 18, 1995
Company
Faulding (Canada) Inc.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Vasodilator

Products in this notice

BrandDINStatus today
NITROGLYCERIN02182734—

Medicinal ingredients